Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Adjuvants

SDS gel electrophoresis is often the last step in antigen purification. Antigens in gels can be processed in the following ways (I prefer C). [Pg.141]

Chiles, T., et al. (1987). Production of Monoclonal Antibodies to a Low-abundance Hepatic Membrane Protein Using Nitrocellulose Immobilized Protein as Antigen, Anal. Biochem. 163 136-142. [Pg.141]

(1987). A method for the Production of Highly Specific Antibodies, Anal. Biochem. 166 224-229. [Pg.141]

Hirokawa, N. (1978). Characterization of Various Nervous Tissues of the Chick Embryos Through Responses to Chronic Application and Immunocytochemistry of (i-bungarotoxin, J. Camp. Neurol. 180 449 466. [Pg.141]

An adjuvant is vital for the success of an immunization. It works as a depot for the antigen and increases the immunological reaction of the animal. There are many adjuvants. Among experimenters, the most popular one is Freund s adjuvant (FA). Pierce offers two adjuvants, Imject Alum and AdjuPrime, which supposedly are better tolerated by the animal to be immunized. [Pg.141]


Additional nonnutrient additives iaclude sequestrants to provide ingredient separatioa and stabili2ers such as gums. Spices, essential oils, oleoresias, synthetic flavotings, and adjuvants are also used ia pet foods. [Pg.151]

Health and Safety. The U.S. FDA has affirmed R%- and S(—)-maHc acid as substances that are generally recognized as safe (GRAS) as flavor enhancers, flavoring agents and adjuvants, and as pH control agents at levels ranging from 6.9% for hard candy to 0.7% for miscellaneous food uses (42). R%- and A(—)-maHc acid may not be used in baby foods. MaHc acid is also cleared to correct natural acid deficiencies in juice or wine (43). [Pg.523]

The immunorestorative potential of inosiplex has been evaluated in several clinical conditions, including post-surgical trauma, cancer patients with concurrent viral infections, and cancer patients receiving radiotherapy or chemotherapy. For example, most (84%) of the surgery patients remained immunologicaHy depressed, but 56% of the inosiplex-treated surgery patients had complete restoration of normal skin test reactivity (probability level < 0.0005). The use of inosiplex as an adjuvant to chemotherapy or radiotherapy appears to be valuable in the prophylaxis against opportunistic infections. [Pg.36]

Formulation. Compressed tablet formulations contain several types of inert, adjuvant ingredients necessary for proper preparation and therapeutic performance. Tablets designed to be swallowed need diluent, disintegrating, binding (adhesive), and lubricating inert ingredients, whereas... [Pg.229]

A significant use of ethoxylated and propoxylated amines is as antistatic agents (qv) in the textile and plastics industry (86). Ethoxylates are also used in the agricultural area as adjuvants. Ethoxylated fatty amines and derivatives are available from Akzo Chemicals Inc. (Ethomeen) (73) Henkel Corporation (Trymeen) (87) GAE Chemicals Corporation (RhcJ)ne Poulenc) (Katapol) (88) Jetco Chemicals Inc. (The Procter Gamble Company) (fet Amine) (75) Mazer Chemicals (PPG Industries) (Mazeen) (89) Sherex (Adogen) (76) and Tomah Products (Exxon Chemical Company) (Tomah E) (77). [Pg.223]

Florida, Illinois, Louisiana, Massachusetts, New Jersey, Pennsylvania, and Rhode Island (43). 1-Propanol is allowed as a flavoting substance and adjuvants according to 21 CFR 172.515 (48), and is exempted from the requirement of tolerance when used as a solvent or cosolvent iu pesticide formulations (49) (see Flavors AND spices Pesticides). [Pg.120]

Pentoxifylline is stmcturaHy related to other methylxanthine derivatives such as caffeine [58-02-2] (1,3,7-trimethylxanthine), theobromine [83-67-0] (3,7-dimethylxanthine), and theophylline [58-55-9] (3,7-dihydro-1,3-dimethyl-1 H-piirine-2,6-dione or 1,3-dimethylxanthine), which also show radioprotective activity in some instances, suggesting that methylxanthines as a dmg class may radioprotect through a common mechanism (see Alkaloids). In a retrospective analysis of cervical and endometrial cancer patients receiving primary or adjuvant XRT, no association between caffeine consumption and incidence of acute radiation effects has been found. However, there was a decreased incidence of severe late radiation injury in cervical cancer patients who consumed higher levels of caffeine at the time of thek XRT (121). The observed lack of correlation between caffeine consumption and acute radiation effects is consistent with laboratory investigations using pentoxifylline. [Pg.492]

Other U.S. regulatory clearances for sorbic acid allow its use as an antimicotic in the manufacture of food packaging materials (159), as a pesticide adjuvant when appHed to growing crops (160), and with methylceUulose and dimethylpolysiloxane as an antifoaming agent (161). [Pg.287]

The final vacciae coataHis the two toxoids, as weU as pertussis (whole ceU or aceUular), a buffer, and an adjuvant, ie, a substance that Hicreases the response to an antigen when combHied with the antigen, eg, aluminum. As noted above, the final vacciae can also contain a component that protects against Haemophilus disease. [Pg.357]

Vaccine candidates are based on the two viral surface proteins, gD and gB (80). Recombinant methods are used to express the proteins, either in Chinese hamster ovary (CHO) cells or in baculovims. The proteins are purified as subunits and formulated with different adjuvants. Clinical trials with these vaccine candidates have been performed, but the results to date have not been encouraging. [Pg.359]

Adjuvants are substances which can modify the immune response of an antigen (139,140). With better understanding of the functions of different arms of the immune system, it is possible to explore the effects of an adjuvant, such that the protective efficacy of a vaccine can be improved. At present, aluminum salt is the only adjuvant approved for use in human vaccines. New adjuvants such as QS-21, 3D-MPL, MF-59, and other liposome preparations are being evaluated. Several of these adjuvants have been in clinical trial, but none have been approved for human use. IL-12 has been proposed as an adjuvant which can specifically promote T-helper 1 ceU response, and can be a very promising adjuvant for future vaccine development. [Pg.361]

R. Eby, in M. PoweU and M. Newman, eds.. Vaccine Design The Subunit and Adjuvant Approach, Plenum Press, New York, 1995, Chapt. 31. [Pg.363]

Several other antigens with good immunocontraceptive potential have been identified and investigated in laboratory animals. In most studies, the rate and duration of the immunocontraceptive effect are less than acceptable. A potential problem in immunological approaches to antifertUity research is the need for a safe, effective adjuvant and suitable animal models for evaluating the efficacy and safety of methods (111). Newer and more effective adjuvants are required for contraceptive vaccines and vaccines in general. [Pg.123]

The effects of dmgs and adjuvants must be assessed, both in short-term administration and during chronic treatment. Local effects include changes in mucocihary clearance, cell damage, and irritation. Chronic erosion of the mucous membrane may lead to inflammation, hyperplasia, metaplasia, and deterioration of normal nasal function (76). [Pg.227]

The full extent of the toxicity of pesticides to aquatic life is not known. Although chronic toxicity testing is required for new substances, little is known about the long-term effects of older pesticides. Also, very little is known about the toxicity and occurrence of the products formed when pesticides break down (metabolites) or the many non-pesticidal additives (co-formulants and adjuvants) used in pesticide formulations. However, the future is looking brighter. New modelling techniques, EQS development, and the involvement of the NRA in the pesticide registration process, coupled with the development of newer, less persistent pesticides with lower dose rates, all should help to reduce the risk of pesticide pollution. [Pg.56]

The main purpose of pesticide formulation is to manufacture a product that has optimum biological efficiency, is convenient to use, and minimizes environmental impacts. The active ingredients are mixed with solvents, adjuvants (boosters), and fillers as necessary to achieve the desired formulation. The types of formulations include wettable powders, soluble concentrates, emulsion concentrates, oil-in-water emulsions, suspension concentrates, suspoemulsions, water-dispersible granules, dry granules, and controlled release, in which the active ingredient is released into the environment from a polymeric carrier, binder, absorbent, or encapsulant at a slow and effective rate. The formulation steps may generate air emissions, liquid effluents, and solid wastes. [Pg.70]

Beffirdeningsmittel) n. aid, promoter, means of forwarding (Med.) adjuvant, befrachten, v.t. load. [Pg.60]

Forderung, /. furthering, etc. (see fordern). Fbrderungsnuttel, n. Ph/irm.) adjuvant. Forder-werk, n. conveyer elevator, lift. [Pg.161]

Methyl ethyl (7-methoxy-10-methyl-3-phenthiazinyl)malonate (62.2 grams) followed by methyl iodide (45.7 grams) is added to a solution of sodium (4.45 grams) in anhydrous ethanol (500 cc). The reaction mixture is heated under reflux for 1 hour at 45°C, then for 6 hours at 55°C, and finally concentrated to dryness under reduced pressure (20 mm Hg). The residue is taken up in methylene chloride (300 cc) and water (250 cc), filtered in the presence of a filtration adjuvant, washed with methylene chloride (150 cc) and water (150 cc), and decanted. The aqueous solution is extracted once again with methylene chloride (100 cc), and the combined organic solutions washed with water (100 cc), aqueous 0.1 N sodium hyposulfite solution (200 cc) and finally with water (200 cc). After drying over anhydrous sodium sulfate and evaporation to dryness under reduced pressure (20 mm Hg), there is obtained an oil (64.8 grams) which is dissolved in methylene chloride (100 cc) and... [Pg.1322]

Oxaliplatin belongs to the group of diaminocyclohex-ane platinum complexes that can overcome platinum resistance. Its place in the primary and adjuvant treatment of colon cancets is being defined. It is prominently neurotoxic. [Pg.57]

MTX is part of curative therapeutic schedules for acute lymphoblastic leukemias (ALL), Burkitt s lymphoma, and choriocarcinoma. It was also used in adjuvant therapy of breast cancer. High dose MTX with leucovorin rescue can induce about 30% remissions in patients with metastatic osteogenic sarcoma. MTX is one of the few antineoplastic drugs that can be safely administered intrathecally for the treatment of meningeal metastases and leukemic infiltrations (routine prophylaxis in ALL). In addition, MTX can be used as an immunosuppressive agent for the treatment of severe rheumatoid arthritis and psoriasis. [Pg.148]

One commonly used agent is the antimetabolite 5-fluorouracil (5-FU), which is frequently used as an adjuvant therapy in conjunction with surgical excision in the treatment of solid tumors. p53 can directly trigger apoptosis in cells exposed to 5-FU in vitro [1]. In addition, there is a substantial amount of clinical... [Pg.319]


See other pages where Adjuvants is mentioned: [Pg.18]    [Pg.82]    [Pg.381]    [Pg.548]    [Pg.25]    [Pg.34]    [Pg.41]    [Pg.145]    [Pg.143]    [Pg.143]    [Pg.186]    [Pg.432]    [Pg.489]    [Pg.497]    [Pg.152]    [Pg.152]    [Pg.361]    [Pg.361]    [Pg.271]    [Pg.287]    [Pg.117]    [Pg.227]    [Pg.517]    [Pg.212]    [Pg.363]    [Pg.3]    [Pg.94]    [Pg.264]    [Pg.353]   
See also in sourсe #XX -- [ Pg.131 ]

See also in sourсe #XX -- [ Pg.193 , Pg.196 , Pg.197 , Pg.198 ]

See also in sourсe #XX -- [ Pg.751 , Pg.755 ]

See also in sourсe #XX -- [ Pg.123 ]

See also in sourсe #XX -- [ Pg.235 ]

See also in sourсe #XX -- [ Pg.83 , Pg.84 , Pg.86 , Pg.506 ]

See also in sourсe #XX -- [ Pg.280 ]

See also in sourсe #XX -- [ Pg.425 , Pg.429 ]

See also in sourсe #XX -- [ Pg.127 ]

See also in sourсe #XX -- [ Pg.3 , Pg.118 , Pg.155 ]

See also in sourсe #XX -- [ Pg.110 , Pg.113 , Pg.775 , Pg.776 , Pg.796 ]

See also in sourсe #XX -- [ Pg.30 ]

See also in sourсe #XX -- [ Pg.578 ]

See also in sourсe #XX -- [ Pg.82 ]

See also in sourсe #XX -- [ Pg.425 , Pg.429 ]

See also in sourсe #XX -- [ Pg.496 ]

See also in sourсe #XX -- [ Pg.141 ]

See also in sourсe #XX -- [ Pg.83 , Pg.94 , Pg.264 , Pg.321 , Pg.336 , Pg.343 , Pg.366 , Pg.371 , Pg.376 , Pg.377 , Pg.386 , Pg.390 , Pg.495 , Pg.530 , Pg.616 ]

See also in sourсe #XX -- [ Pg.399 ]

See also in sourсe #XX -- [ Pg.2 , Pg.3 , Pg.4 , Pg.5 , Pg.100 , Pg.102 ]

See also in sourсe #XX -- [ Pg.65 , Pg.79 ]




SEARCH



A mouse bioassay for the detection of adjuvant effect

Additional adjuvants

Adjuvant Effect - Adigor

Adjuvant Pharmacological Therapy for HAD

Adjuvant activity Subject

Adjuvant activity of Gypsophila

Adjuvant activity of Quillaia

Adjuvant activity of Saponaria

Adjuvant analgesics

Adjuvant arthritis

Adjuvant arthrits

Adjuvant cancer treatment

Adjuvant complete

Adjuvant composition

Adjuvant drug treatment

Adjuvant effect of plasticizers

Adjuvant effects

Adjuvant hepatic arterial infusion

Adjuvant immune response

Adjuvant in agrochemicals

Adjuvant incomplete

Adjuvant induced polyarthritis

Adjuvant lipid

Adjuvant patenting

Adjuvant preparation

Adjuvant solvent

Adjuvant technology

Adjuvant therapy

Adjuvant therapy chemotherapy

Adjuvant types

Adjuvant, Freund

Adjuvant-induced arthritis

Adjuvant-like effect

Adjuvanted influenza vaccine

Adjuvants Toll-like receptors

Adjuvants accelerator

Adjuvants acquired immunity

Adjuvants activity

Adjuvants adjuvant action

Adjuvants adjuvant activity

Adjuvants adjuvant effect

Adjuvants aluminum

Adjuvants and the Mucosal Surface

Adjuvants antigens

Adjuvants fish immune responses

Adjuvants future trends

Adjuvants innate immune responses

Adjuvants insecticides

Adjuvants mineral-based

Adjuvants mode of action

Adjuvants radiation protectants

Adjuvants vaccination strategies

Adjuvants vaccines with substances other

Adjuvants, field trials

Adjuvants, function

Adjuvants, organophosphorus

Adjuvants, organophosphorus insecticides

Adjuvants, pesticides

Adjuvents

Adjuvents

Adsorbents aluminum hydroxide adjuvant

Advantages of Molecular Adjuvant-Containing Vaccines

Agrochemical adjuvants

Aluminium hydroxide adjuvant

Aluminium-based adjuvants

Aluminum adjuvants vaccines

Aluminum hydroxide adjuvant

Aluminum phosphate adjuvant

Analgesic drugs adjuvant

Anesthetic drugs adjuvants

Antibodies, vaccines and adjuvants

Antibody adjuvant

Antibody adjuvant selection

Autoimmune diseases adjuvant effect

Bacillus thuringiensis adjuvants

Bacterial adjuvants

Breast cancer systemic adjuvant therapy

Cancer adjuvant

Cancer adjuvant therapy

Cationic Peptide Delivery Systems in Combination with Other Adjuvants

Chemotherapy adjuvant

Chiral adjuvants

Cholera Adjuvant

Colorectal cancer adjuvant chemotherapy

Colorectal cancer adjuvant therapy

Complement-derived molecular adjuvants

Complete Freund s Adjuvant

Complete freunds adjuvant

Complete freunds adjuvant (CFA

Corynebacterium adjuvants

Cyclopeptide-Based Glycoclusters as Vaccine Adjuvants

Derived Molecular Adjuvants

Effective vaccine adjuvants

Emulsifiers adjuvant effect

Environmental adjuvants

Filtration adjuvants

Food adjuvants

Formulations and adjuvants

Freunds Adjuvant

Freund’s Complete Adjuvant Test

Freund’s adjuvant

Freund’s complete adjuvance

Freund’s incomplete adjuvant

From Freunds Adjuvant to MDP

Gastric cancer adjuvant therapy

Gene therapy adjuvants with

General Adjuvants Vehicles and Immunomodulators

Herceptin Adjuvant Trials

Human adjuvant disease

Immune adjuvants

Immune-stimulating complexes adjuvanted vaccine

Immunization adjuvant preparation

Immunogen adjuvant

Immunological adjuvants

Incomplete Freunds adjuvant

Liposomes adjuvant effect

Lung cancer adjuvant therapy

Malignant disease adjuvant treatment

Melanoma adjuvant therapy

Mineral adjuvants

Mineral oil adjuvants

Molecular Adjuvant Design N-Methylation of Backbone Amides

Mucosal adjuvants

Multiple emulsions vaccine adjuvants

Mycobacterial adjuvants

Mycobacterium adjuvant arthritis

National Surgical Adjuvant Breast and

National Surgical Adjuvant Breast and Bowel

National Surgical Adjuvant Breast and Bowel Project

New Vaccine Adjuvants and Other Excipients

Novel Vaccine Adjuvants Based on Cationic Peptide Delivery Systems

Oil-adjuvanted fish vaccines

Oil-in-water adjuvant

Oral vaccination mucosal adjuvants

Peptide adjuvant

Pharmaceutical adjuvants

Phenol chemistry, formulations and adjuvants

Phenol peels adjuvants

Plasticizer adjuvant effect

Polyclonal antibodies adjuvant

Protein adjuvant

Rat adjuvant arthritis model

Reactions Between Penicillins and Pharmaceutical Adjuvants

Rectal cancer adjuvant therapy

Rheumatoid arthritis adjuvant-induced

Split adjuvant test

Spray adjuvants

Surfactant adjuvants

Synergistic adjuvants

Syntex adjuvant

Therapy adjuvant measures

Vaccine Adjuvants and Delivery Systems

Vaccine adjuvants aluminum hydroxide adjuvant

Vaccine adjuvants aluminum phosphate adjuvant

Vaccine technology adjuvants

Vaccine toxicology adjuvants

Vaccines adjuvanted with substances other than oil

Vaccines adjuvants

Vaccines adjuvants for

Veterinary vaccines, adjuvants

Virosomes as Adjuvants in Cancer Immunotherapy

Water soluble adjuvant

© 2024 chempedia.info